WAVE SNP1 & SNP2 – Wave Life Sciences – Enrollment to begin August 2017

Study Sponsor:  Wave Life Sciences

Not a Clinical Trial:  It is an Observational Study to Determine the Presence of SNP1 or SNP2

Clinical Sites in NC: Wake Forest

Website:  http:// www.wavelifesciences.com

Description: The purpose of the study is to find out the prevalence of the SNP1 and/or SNP2 in HD patients. The study consists of one visit for a brief exam and blood specimen collection.  The results will be used as a potential pre-screening tool for the PRECISION-HD study.  It is expected that about 20-30% of patients will not have SNP1 or SNP2 and will therefore be ineligible for the PRECISION-HD study.